UNCLAIMED
Evinova
Overview
Evinova, founded in 2023 and based in Switzerland, operates within the healthcare software sector, focusing on the integration of digital health technologies into clinical trials. With a workforce of 201 to 500 employees and reported revenue of approximately 16.5 million USD, the company is positioned to enhance the efficiency and effectiveness of clinical research. Evinova's published content, including a recent article in *Nature Medicine*, discusses the implementation of digital health solutions in clinical trials, emphasizing the benefits of remote patient monitoring and the collection of patient-generated data through digital devices. This approach aims to optimize participant experiences, streamline trial processes, and improve data accuracy by utilizing tools such as smart spirometers and virtual visit platforms. The article highlights the shift from traditional site-based models to more flexible, home-based data collection methods, which can lead to increased statistical power and precision in evaluating treatment efficacy. Evinova's focus on these innovative solutions reflects its commitment to advancing healthcare through technology.